by Corina Milic | Jul 19, 2015
CHAI and global partners in the Diagnostics Access Initiative have joined with Roche Diagnostics to announce a 35 percent reduction in the price for HIV early infant diagnostic technologies. The new access price is US$9.40 per test, including proprietary reagents and...
by Corina Milic | Jul 16, 2015
CHAI’s Research and Development (R&D) Team works from a unique angle to support CHAI’s ambitions to improve patient outcomes in low- and middle-income countries. In particular, the team works to: 1. Identify, develop, validate, and transfer for manufacture and...
by Corina Milic | May 26, 2015
ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV London, May 26, 2015 – ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access...
by Corina Milic | Apr 9, 2015
New agreement will help save mothers’ lives in low-income countries April 8, 2015 An agreement announced today will reduce the achievable cost per use of the non-pneumatic anti-shock garment (NASG) by over 75 percent and expand access to this innovative new...
by Corina Milic | Apr 1, 2015
Clinton Health Access Initiative, Inc. Donor Disclosure Policy – Q & A April 16, 2015 Q: Why is CHAI’s policy different from the Clinton Foundation’s policy? CHAI is an independent 501c3 charitable organization, separate from the Clinton Foundation. CHAI operates...
by Corina Milic | Feb 26, 2015
In 2019, updates to historical datasets were made upon consultation with relevant current suppliers, including the addition of a new supplier’s data. Please find the most up-to-date report here. The 2015 Family Planning Market Report can be found below. Download...
by Corina Milic | Feb 25, 2015
NEWS RELEASE CONTACT: Amy Tolchinsky, 404.523.3486, atolchinsky@cdcfoundation.org FOR IMMEDIATE RELEASE: February 25, 2015 Consortium Aims to Eliminate Malaria on Hispaniola by 2020 Starting With $29.9 Million Grant to CDC Foundation Collaborative Initiative Funded by...
by Corina Milic | Feb 16, 2015
CHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS. CHAI offers reduced prices for antiretrovirals (ARVs) to members of its Procurement Consortium. See the 2014 ARV Ceiling Price List here.
by Corina Milic | Feb 11, 2015
HIV viral load testing improves the quality of care for patients on antiretroviral therapy. CHAI partnered with the Government of South Africa, UNAIDS, PEPFAR, Global Fund to Fight AIDS, Tuberculosis and Malaria, and Roche to negotiate a global access price for viral...
by Corina Milic | Feb 9, 2015
CHAI’s Demand-Driven Evaluations for Decisions (3DE) program is a pioneering approach to support ministries in the health sector with evidence-based decision-making by using rigorous impact evaluations in a demand-driven, rapid, and efficient way. The 3DE...
